Is $MBRX- The Best Biotech with the most upside Potential
Diupdate
Is 
MBRX- The Best Biotech with the most upside Potential
Just announced a major breakthrough in its effort to develop a new cancer treatment that selectively kills highly resistant tumors. Company has a relatively small OS under 25 Mil and float under 15 Mil . The company is working with the most prestigious cancer centers to treat a broader range of the most difficult cancers like pancreatic cancer. There is a huge unmet medical need in treating these hard to treat cancers andMBRX break through with STAT3 inhibitors is a game-changer for treating cancer patients.
As thing progress I expect this to have 5-10x potential in the relative short term and possible a 50x + in the long term..
One you might want to research and stick away in your IRA ..
As i write this stock is 2.05 , recent offer was done ar 2.10 so you know institutional savy investors see major upside and are getting involved at these levels..
MBRX- The Best Biotech with the most upside Potential Just announced a major breakthrough in its effort to develop a new cancer treatment that selectively kills highly resistant tumors. Company has a relatively small OS under 25 Mil and float under 15 Mil . The company is working with the most prestigious cancer centers to treat a broader range of the most difficult cancers like pancreatic cancer. There is a huge unmet medical need in treating these hard to treat cancers and
MBRX break through with STAT3 inhibitors is a game-changer for treating cancer patients.As thing progress I expect this to have 5-10x potential in the relative short term and possible a 50x + in the long term..
One you might want to research and stick away in your IRA ..
As i write this stock is 2.05 , recent offer was done ar 2.10 so you know institutional savy investors see major upside and are getting involved at these levels..
Catatan
Recent Covid Cure news could really be a game changer here.Stock still under 54 MiL Shares and potential treatment for coronavirus.
finance.yahoo.com/news/moleculin-announces-active-compound-wp1122-113000553.html
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.